Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Bonnet

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Bioinformatics (Oxford, England)|August 19, 2025
Spatio-temporal learning from molecular dynamics simulations for protein-ligand binding affinity predictionPierre-Yves Libouban, Camille Parisel, Maxime Song, et al.
Chemical Communications (Cambridge, England)|June 19, 2019
An original class of small sized molecules as versatile fluorescent probes for cellular imagingDoina Sirbu, Julien Diharce, Ivana Martinić, et al.
European Journal of Medicinal Chemistry|May 6, 2014
Synthesis and optimization of an original V-shaped collection of 4-7-disubstituted pyrido[3,2-d]pyrimidines as CDK5 and DYRK1A inhibitorsOussama Dehbi, Abdellatif Tikad, Stéphane Bourg, et al.
European Journal of Medicinal Chemistry|October 10, 2015
Synthesis of dihydropyrimidine α,γ-diketobutanoic acid derivatives targeting HIV integraseOzkan Sari, Vincent Roy, Mathieu Métifiot, et al.
Molecules (Basel, Switzerland)|August 31, 2018
Development of Kinase Inhibitors via Metal-Catalyzed C⁻H Arylation of 8-Alkyl-thiazolo[5,4-<i>f</i>]-quinazolin-9-ones Designed by Fragment-Growing StudiesFlorence Couly, Marine Harari, Carole Dubouilh-Benard, et al.
Bioorganic & Medicinal Chemistry|January 16, 2007
Benzoic acid and pyridine derivatives as inhibitors of Trypanosoma cruzi trans-sialidaseJoão Neres, Pascal Bonnet, Philip N Edwards, et al.
Journal of Medicinal Chemistry|October 22, 2016
An Unusual Binding Model of the Methyl 9-Anilinothiazolo[5,4-f] quinazoline-2-carbimidates (EHT 1610 and EHT 5372) Confers High Selectivity for Dual-Specificity Tyrosine Phosphorylation-Regulated KinasesApirat Chaikuad, Julien Diharce, Martin Schröder, et al.
Molecular Biology of the Cell|December 25, 2009
Autophosphorylation of polo-like kinase 4 and its role in centriole duplicationJames E Sillibourne, Frederik Tack, Nele Vloemans, et al.
European Journal of Medicinal Chemistry|March 6, 2023
Design, synthesis and characterisation of a novel type II B-RAF paradox breaker inhibitorRohit Arora, Joannes T M Linders, Samia Aci-Sèche, et al.
International Journal of Cosmetic Science|February 8, 2024
Randomized double-blind placebo-controlled cosmetic trial of a topical first-in-class Neutraligand targeting the chemokine TARC/CCL17 in mild-to-moderate atopic dermatitisNelly Frossard, Alexandra Coïc, Thibaut Saguet, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Bioinformatics (Oxford, England)|August 19, 2025
Spatio-temporal learning from molecular dynamics simulations for protein-ligand binding affinity predictionPierre-Yves Libouban, Camille Parisel, Maxime Song, et al.
Chemical Communications (Cambridge, England)|June 19, 2019
An original class of small sized molecules as versatile fluorescent probes for cellular imagingDoina Sirbu, Julien Diharce, Ivana Martinić, et al.
European Journal of Medicinal Chemistry|May 6, 2014
Synthesis and optimization of an original V-shaped collection of 4-7-disubstituted pyrido[3,2-d]pyrimidines as CDK5 and DYRK1A inhibitorsOussama Dehbi, Abdellatif Tikad, Stéphane Bourg, et al.
European Journal of Medicinal Chemistry|October 10, 2015
Synthesis of dihydropyrimidine α,γ-diketobutanoic acid derivatives targeting HIV integraseOzkan Sari, Vincent Roy, Mathieu Métifiot, et al.
Molecules (Basel, Switzerland)|August 31, 2018
Development of Kinase Inhibitors via Metal-Catalyzed C⁻H Arylation of 8-Alkyl-thiazolo[5,4-<i>f</i>]-quinazolin-9-ones Designed by Fragment-Growing StudiesFlorence Couly, Marine Harari, Carole Dubouilh-Benard, et al.
Bioorganic & Medicinal Chemistry|January 16, 2007
Benzoic acid and pyridine derivatives as inhibitors of Trypanosoma cruzi trans-sialidaseJoão Neres, Pascal Bonnet, Philip N Edwards, et al.
Journal of Medicinal Chemistry|October 22, 2016
An Unusual Binding Model of the Methyl 9-Anilinothiazolo[5,4-f] quinazoline-2-carbimidates (EHT 1610 and EHT 5372) Confers High Selectivity for Dual-Specificity Tyrosine Phosphorylation-Regulated KinasesApirat Chaikuad, Julien Diharce, Martin Schröder, et al.
Molecular Biology of the Cell|December 25, 2009
Autophosphorylation of polo-like kinase 4 and its role in centriole duplicationJames E Sillibourne, Frederik Tack, Nele Vloemans, et al.
European Journal of Medicinal Chemistry|March 6, 2023
Design, synthesis and characterisation of a novel type II B-RAF paradox breaker inhibitorRohit Arora, Joannes T M Linders, Samia Aci-Sèche, et al.
International Journal of Cosmetic Science|February 8, 2024
Randomized double-blind placebo-controlled cosmetic trial of a topical first-in-class Neutraligand targeting the chemokine TARC/CCL17 in mild-to-moderate atopic dermatitisNelly Frossard, Alexandra Coïc, Thibaut Saguet, et al.
Pageof 8